Back
Biomarin Pharmaceutical Vs. Bristol-Myers Squibb Industry Stock Comparison
Buy
57
BMRN
Biomarin Pharmaceutical
Last Price:
77.57
Seasonality Move:
0.55%
Sell
35
BMY
Bristol-Myers Squibb
Last Price:
44.01
Seasonality Move:
-0.39%
Buy
57
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $77.56. The Score for BMRN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Bristol-Myers Squibb (BMY)
is a Sell
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $44.03. The Score for BMY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- BMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $77.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $44.03
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMY is experiencing slight buying pressure.
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.33 | Sell |
Relative Strength Index (14 RSI): | 32.11 | Sell |
Chaikin Money Flow: | 1712816 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (79.52 - 88.82) | Sell |
Bollinger Bands (100): | (83.55 - 93.21) | Sell |
BMY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.27 | Sell |
Relative Strength Index (14 RSI): | 32.78 | Sell |
Chaikin Money Flow: | 811113 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.66 - 47.74) | Sell |
Bollinger Bands (100): | (46.83 - 52.49) | Sell |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 79.96 | Sell |
20-day SMA: | 82.63 | Sell |
50-day SMA: | 85.45 | Sell |
200-day SMA: | 88.6 | Sell |
8-day EMA: | 79.65 | Sell |
20-day EMA: | 82.13 | Sell |
50-day EMA: | 84.92 | Sell |
200-day EMA: | 88.49 | Sell |
BMY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.48 | Sell |
20-day SMA: | 45.04 | Sell |
50-day SMA: | 48.89 | Sell |
200-day SMA: | 52.74 | Sell |
8-day EMA: | 44.42 | Sell |
20-day EMA: | 45.36 | Sell |
50-day EMA: | 47.54 | Sell |
200-day EMA: | 53 | Sell |
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.18 per share, an increase this year of $0.83 per share, and an increase next year of $0.93 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.21 per share, a decrease this year of $6.83 per share, and an increase next year of $6.39 per share.
Biomarin Pharmaceutical Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bristol-Myers Squibb Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |